Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $2.76 on Friday, April 25 with a fall of -1.43% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $2.80 and 5Y monthly beta was reading 1.023 with its price kept floating in the range of $2.6603 and $2.85 on the day. Considering stock’s 52-week price range provides that RGLS hit a high price of $2.90 and saw its price falling to a low level of $0.83 during that period. Over a period of past 1-month, stock came adding 113.95% in its value.
With its current market valuation of $182.83 million, Regulus Therapeutics Inc is set to declare its quarterly results on 2025-Mar-12. Analysts are in estimates of -0.26 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -1.22 for current year with estimates of that growing to -1.56 in next year.
In contrast, when we review RGLS stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 50% Buy for it.
According to ratings assigned by 1 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Regulus Therapeutics Inc (RGLS) as a Hold, while 1 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the RGLS stock which is currently positioned at 0. It further provides that stock’s current price level is 40.15% away from its 20-day simple moving average and is 73.53% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 79.92 while volatility remained at 11.79% over the past week which changes to 14.09% when measuring it over the past month. Beta is valued at 0.88, while measure of average true range or ATR is currently at 0.21.
Having a second look at Regulus Therapeutics Inc (NASDAQ:RGLS) provides that stock’s average daily trading volume for 3 months was 1.24 million, while it jumped to 950950 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 65.50 million.
The percentage of outstanding shares held by the insiders is 19.71% while it is 67.96% for the institutional holders. The figures also indicate that as of 2025-03-31, number of stock’s short shares was 2.66 million which implies a short ratio of 1.36. This shows up a 508.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 2.24 million in the previous month. Addition of 74.68% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
